FIGURE 10
![Gut Microbiome Analysis. (A): Hierarchical clustering of species classified by MetaPhlAn2 by patient. (B): Shannon diversity by patient and day of collection. (C): Significant organisms determined by linear discriminant analysis effect size per survival outcomes (blue, progression‐free survival [PFS] >6 months; red, PFS <6 months).](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/oncolo/26/2/10.1002_onco.13583/5/oncolo_26_2_99_f10.jpeg?Expires=1749317714&Signature=bZ4oSEk0vMmze5kG9fY6znCUVAQ5MzRFy4R9jBSEAxcDEZw9GetixIyWkeAXsE2EOO2P9qR~k79SFWeI5lg2doxdX1O9Ybno9WCl3maQnN92q~Z0rFBPwSSZA1drxgJVGGGDMPmLYN3kx2XkWjt7ZAv6h4NPyBnk6hzBrv3w-Zom5m1rdCDaKyvvNEdmnLFUl4xq2iib7UZ7RSxUOhGflJnOBn0hBhnQUmc8dulVzAZ1S0afX-8moBZDoNYDsmkCcrv7fNpAHuJGbx1LPTvndCoen3~IVhroXas6Lo638R8iLikkZhHWoYBi08VLQpsSY3Z0EoACAyi8mT~GeIYVyw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Gut Microbiome Analysis. (A): Hierarchical clustering of species classified by MetaPhlAn2 by patient. (B): Shannon diversity by patient and day of collection. (C): Significant organisms determined by linear discriminant analysis effect size per survival outcomes (blue, progression‐free survival [PFS] >6 months; red, PFS <6 months).
Abbreviations: CR, complete response; LDA, linear discriminant analysis; PD, progressive disease; PR, partial response; SD, stable disease.
